Total Debt
$17M
Net Debt
-$97.7M
Aura Biosciences, Inc. currently has $17M in total debt. Net debt is -$97.7M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
AURA • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.02 | 0.11 | -0.10Net Cash | 0.14 | 12.3% |
| 2025-12-31 | 0.02 | 0.14 | -0.13Net Cash | 0.17 | 10.3% |
| 2025-09-30 | 0.02 | 0.16 | -0.14Net Cash | 0.19 | 9.3% |
| 2025-06-30 | 0.02 | 0.18 | -0.16Net Cash | 0.20 | 8.9% |
| 2025-03-31 | 0.02 | 0.13 | -0.11Net Cash | 0.16 | 11.9% |
| 2024-12-31 | 0.02 | 0.15 | -0.13Net Cash | 0.18 | 10.3% |
| 2024-09-30 | 0.02 | 0.17 | -0.16Net Cash | 0.21 | 9.3% |
| 2024-06-30 | 0.02 | 0.19 | -0.17Net Cash | 0.22 | 8.7% |
| 2024-03-31 | 0.02 | 0.20 | -0.18Net Cash | 0.24 | 8.2% |
| 2023-12-31 | 0.02 | 0.23 | -0.21Net Cash | 0.26 | 7.7% |
| 2023-09-30 | 0.02 | 0.15 | -0.13Net Cash | 0.18 | 11.2% |
| 2023-06-30 | 0.02 | 0.16 | -0.14Net Cash | 0.19 | 10.6% |
| 2023-03-31 | 0.02 | 0.17 | -0.15Net Cash | 0.21 | 10.0% |
| 2022-12-31 | 0.02 | 0.19 | -0.17Net Cash | 0.22 | 9.3% |
| 2022-09-30 | 0.02 | 0.11 | -0.09Net Cash | 0.14 | 14.7% |
| 2022-06-30 | 0.00 | 0.12 | -0.12Net Cash | 0.14 | 0.5% |
| 2022-03-31 | 0.00 | 0.13 | -0.13Net Cash | 0.15 | 0.6% |
| 2021-12-31 | 0.00 | 0.15 | -0.15Net Cash | 0.16 | 0.6% |
| 2021-09-30 | 0.00 | 0.08 | -0.08Net Cash | 0.09 | 1.2% |
| 2021-06-30 | 0.00 | 0.09 | -0.09Net Cash | 0.10 | 1.3% |
| 2021-03-31 | 0.00 | 0.10 | -0.10Net Cash | 0.11 | 0.8% |
| 2020-12-31 | 0.00 | 0.02 | -0.02Net Cash | 0.02 | 0.1% |